The Comparative Efficacy of Intravenous Magnesium and Lidocaine on Postoperative Outcomes after Laparoscopic Cholecystectomy

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202509503569442

Enrollment

150

Registered

2025-09-30

Start date

2025-07-31

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Lidocaine Group

Magnesium Group

Placebo Group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: aged between 18 and 65 years, classified as ASA I and ASA II, who signed an informed consent form

Exclusion criteria

Exclusion criteria: Patients in whom the procedure was converted from laparoscopy to laparotomy Occurrence of an intraoperative anesthetic or surgical complication Patients not extubated on the operating table Patients who had a modification of the anesthetic protocol and received the other molecule

Design outcomes

Primary

Measure	Time frame
The time to recovery of intestinal transit (first post-operative flatus or stool)	—

Secondary

Measure	Time frame
Evaluated using the VAS Score (Visual Analog Scale) ;first mobilization/ambulation.;Resumption of Oral Feeding;Total Duration of Hospitalization;Patient satisfaction: evaluated by the Likert scale	—

Countries

Tunisia

Contacts

Public ContactBen Amri Eya

Principal Military Teaching Hospital of Tunis

eya.benamri@gmail.com97711880

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026